What is the recommended dosage of Insulin Mixtard (Biphasic Isophane Insulin)

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 5, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Insulin Mixtard Dosing Recommendations

The recommended dosage of Insulin Mixtard (Biphasic Isophane Insulin) is to start with a total daily dose calculated as 80% of the current NPH insulin dose, divided into two daily injections with 2/3 given before breakfast and 1/3 given before dinner.

Initial Dosing

  • For insulin-naive patients with type 2 diabetes, start with 10 units per day or 0.1-0.2 units/kg/day 1
  • For patients switching from NPH insulin to Mixtard (70/30 premixed insulin), calculate the total daily dose as 80% of the current NPH insulin total daily dose 2
  • Divide the total daily dose into two injections: 2/3 before breakfast and 1/3 before dinner 2, 1

Titration and Adjustment

  • Increase dose by 10-15%, or 2-4 units, once or twice weekly until fasting blood glucose target is met 1
  • Target fasting glucose values should be between 4.0-7.0 mmol/L (72-126 mg/dL) 2
  • Monitor both fasting and postprandial glucose levels to assess the effectiveness of the regimen 2
  • Check blood glucose more frequently during the transition period when switching from NPH to Mixtard 2

Clinical Considerations

  • Mixtard 50 HM (50% regular insulin/50% NPH) may be more appropriate for patients with post-breakfast hyperglycemia compared to Mixtard 30 HM (30% regular insulin/70% NPH) 3
  • Morning doses may need to be higher than evening doses (ratio approximately 55:45 to 60:40) for optimal glycemic control 4
  • Consider reducing the dose if A1C is <8% when switching to avoid hypoglycemia 2

Special Populations

  • For patients with type 1 diabetes, the typical starting dose is 0.5 units/kg/day with half administered as prandial insulin and half as basal insulin 1
  • In children and adolescents with type 1 diabetes, Mixtard 30 HM has been shown to improve glycemic control when administered twice daily 5

Advantages and Limitations

  • Premixed insulin provides both basal and prandial coverage with fewer daily injections, simplifying the regimen compared to separate basal and bolus injections 2
  • However, premixed insulin has less flexibility in dosing compared to basal-bolus regimens 2
  • Consistent meal timing is important with premixed insulin regimens 2

Common Pitfalls to Avoid

  • Converting on a 1:1 basis when switching from NPH to Mixtard (use 80% of NPH dose instead) 2
  • Using the same dose for both morning and evening injections (use 2/3 morning, 1/3 evening) 2
  • Neglecting monitoring during transition period 2
  • Forgetting about meal timing, which is more critical with premixed insulins 2

Delivery Methods

  • NovoPen delivery systems are generally well-accepted by patients and may improve adherence compared to traditional syringes 3, 5
  • The shortest needles (4-mm pen and 6-mm syringe needles) are safe, effective, and less painful 6

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Switching from NPH Insulin to 70/30 Insulin

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

EADSG Guidelines: Insulin Therapy in Diabetes.

Diabetes therapy : research, treatment and education of diabetes and related disorders, 2018

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.